Ketorolac reduces spinal astrocytic activation and PAR1 expression associated with attenuation of pain after facet joint injury

Journal of Neurotrauma

Volumn 30, Issue 10, 2013, Pages 818-825

  Dong, Ling ^a   Smith, Jenell R ^a   Winkelstein, Beth A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Astrocyte; Facet joint; Ketorolac; Pain; PAR1

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; KETOROLAC; PROTEINASE ACTIVATED RECEPTOR 1;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; ATTENUATION; CELL ACTIVATION; CONTROLLED STUDY; FOREFOOT; INJURY SEVERITY; JOINT INJURY; MALE; NONHUMAN; PAIN ASSESSMENT; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SPINAL CORD DORSAL HORN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTROCYTES; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERALGESIA; INJECTIONS, INTRA-ARTICULAR; KETOROLAC; MALE; PAIN, POSTOPERATIVE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PAR-1; SPINAL CORD; ZYGAPOPHYSEAL JOINT;

EID: 84878269595     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2012.2600     Document Type: Article

References (53)

1. Haldeman, S., Carroll, L., Cassidy, J.D., Schubert, J., and Nygren, A. (2008). The Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders: Executive summary. Spine 33, Suppl, S5-S7. (Pubitemid 351155753)
2. Lidgren, L. (2008). Preface: Neck pain and the decade of the bone and joint 2000-2010. Spine 33, Suppl, S1-S2. (Pubitemid 351155750)
3. Barnsley, L., Lord, S.M., Wallis, B.J., and Bogduk, N. (1995). The prevalence of chronic cervical zygapophysial joint pain after whiplash. Spine 20, 20-25.
4. Lord, S.M., Barnsley, L., Wallis, B.J., and Bogduk, N. (1996). Chronic cervical zygapophysial joint pain after whiplash. A placebo-controlled prevalence study. Spine 21, 1737-1745. (Pubitemid 26260290)
5. Inami, S., Shiga, T., Tsujino, A., Yabuki, T., Okado, N., and Ochiai, N. (2001). Immunohistochemical demonstration of nerve fibers in the synovial fold of the human cervical facet joint. J. Orthop. Res. 19, 593-596. (Pubitemid 32700973)
6. Kallakuri, S., Singh, A., Lu, Y., Chen, C., Patwardhan, A., and Cavanaugh, J.M. (2008). Tensile stretching of cervical facet joint capsule and related axonal changes. Eur. Spine J. 17, 556-563.
7. McLain, R.F. (1994). Mechanoreceptor endings in human cervical facet joints. Spine 19, 495-501. (Pubitemid 24108332)
8. Cavanaugh, J.M., Ozaktay, A.C., Yamashita, H.T., and King, A.L. (1996). Lumbar facet pain: biomechanics, neuroanatomy and neurophysiology. J. Biomech. 29, 1117-1129. (Pubitemid 26302177)
9. Kidd, B.L., Morris, V.H., and Urban, L. (1996). Pathophysiology of joint pain. Ann. Rheum. Dis. 55, 276-283. (Pubitemid 26166261)
10. Lee, K.E. and Winkelstein, B.A. (2009). Joint distraction magnitude is associated with different behavioral outcomes and substance P levels for cervical facet joint loading in the rat. J. Pain 4, 436-445.
11. Winkelstein, B.A. and Santos, D.G. (2008). An intact facet capsular ligament modulates behavioral sensitivity and spinal glial activation produced by cervical facet joint tension. Spine 33, 856-862. (Pubitemid 351533853)
12. Lee, K.E., Davis, M.B., Mejilla, R.M., and Winkelstein, B.A. (2004a). In vivo cervical facet capsule distraction: mechanical implications for whiplash and neck pain. Stapp Car Crash J. 48, 373-395.
13. Garcia, P.S., Gulati, A., and Levy, J.H. (2010). The role of thrombin and protease activated receptors in pain mechanisms. Thromb. Haemost. 103,1145-1151.
14. Suo, Z., Citron, B.A., and Festoff, B.W. (2004). Thrombin: a potential proinflammatory mediator in neurotrauama and neurodegenerative disorders. Curr. Drug Targets Inflamm. Allergy 3, 105-114. (Pubitemid 38854895)
15. Coughlin, S.R. (2000) Thrombin signalling and protease-activated receptors. Nature 407, 258-264.
16. Déry, O., Corvera, C.U., Steinhoff, M., and Bunnett, N.W. (1998). Proteinase-activated receptors: novel mechanisms of signaling by proteases. Am. J. Physiol. 274, C1429-C1452.
17. Junge, C.E., Lee, C.J., Hubbard, K.B., Zhang, Z., Olson, J.J., Hepler, J.R., Brat, D.J., and Traynelis, S.F. (2004). Protease-activated receptor- 1 in human brain: localization and functional expression in astrocytes. Exp. Neurol. 188, 94-103. (Pubitemid 38748808)
18. Pompili, E., Fabrizi, C., Nori, S.L., Panetta, B., Geloso, M.C., Corvino, V., Michetti, F., and Fumagalli, L. (2011). Protease-activated receptor-1 expression in rat microglia after trimethyltin treatment. J. Histochem. Cytochem. 59, 302-311.
19. Shavit, E., Michaelson, D.M., and Chapman, J. (2011). Anatomical localization of protease-activated receptor-1 and protease-mediated neuroglial crosstalk on peri-synaptic astrocytic endfeet. J. Neurochem. 119, 460-473.
20. Vellani, V., Kinsey, A.M., Prandini, M., Hechtfischer, S.C., Reeh, P., Magherini, P.C., Giacomoni, C., and McNaughton, P.A. (2010). Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones. Mol. Pain. 6, 61.
21. Wang, H., Ubl, J.J., and Reiser, G. (2002). Four subtypes of proteaseactivated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37, 53-63. (Pubitemid 34103094)
22. Narita, M., Usui, A., Narita, M., Niikura, K., Nozaki, H., Khotib, J., Nagumo, Y., Yajima, Y., and Suzuki, T. (2005). Protease-activated receptor-1 and platelet-derived growth factor in spinal cord neurons are implicated in neuropathic pain after nerve injury. J. Neurosci. 25, 10000-10009. (Pubitemid 41528038)
23. Asfaha, S., Brussee, V., Chapman, K., Zochodne, D.W., and Vergnolle, N. (2002). Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br. J. Pharmacol. 135, 1101-1106. (Pubitemid 34259109)
24. Niclou, S.P., Suidan, H.S., Pavlik, A., Vejsada, R., and Monard, D. (1998). Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur. J. Neurosci. 10, 1509-1607.
25. McMahon, S.B., Cafferty, W.B., and Marchand, F. (2005). Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444-462. (Pubitemid 40341688)
26. Watkins, L.R., Milligan, E.D., and Maier, S.F. (2001). Glial activation: a driving force for pathological pain. Trends Neurosci. 24, 450-455. (Pubitemid 32695356)
27. Watkins, L.R., Milligan, E.D., and Maier, S.F. (2001). Spinal cord glia: new players in pain. Pain 93, 201-205. (Pubitemid 32763176)
28. Cassinelli, E.H., Dean, C.L., Garcia, R.M., Furey, C.G., and Bohlman, H.H. (2008). Ketorolac use for postoperative pain management following lumbar decompression surgery: a prospective, randomized, double-blinded, placebo-controlled trial. Spine 33, 1313-1317.
29. Kim, S.J., Lo, W.R., Hubbard, G.B. 3rd, Srivastava, S.K., Denny, J.P., Martin, D.F., Yan, J., Bergstrom, C.S., Cribbs, B.E., Schwent, B.J., and Aaberg, T.M. Sr. (2008). Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. Arch. Ophthalmol. 126, 1203-1208.
30. Ng, H.P., Nordström, U., Axelsson, K., Perniola, A.D., Gustav, E., Ryttberg, L., and Gupta, A. (2006). Efficacy of intra-articular bupivacaine, ropivacaine, or a combination of ropivacaine, morphine, and ketorolac on postoperative pain relief after ambulatory arthroscopic knee surgery: A randomized double-blind study. Reg. Anesth. Pain. Med. 31, 26-33. (Pubitemid 43097402)
31. Turner, C.L., Eggleston, G.W., Lunos, S., Johnson, N., Wiedmann, T.S., and Bowles, W.R. (2011). Sniffing out endodontic pain: use of an intranasal analgesic in a randomized clinical trial. J. Endod. 37, 439-444.
32. Vintar, N., Rawal, N., Pohar, M., and Veselko, M. (2010). Intra-articular patient-controlled analgesia improves early rehabilitation after knee surgery. Coll. Antropol. 34, 941-945.
33. Dogan, N., Erdem, A.F., Gundogdu, C., Kursad, H., and Kizilkaya, M. (2004). The effects of ketorolac and morphine on articular cartilage and synovium in the rabbit knee joint. Can. J. Physiol. Pharmacol. 82, 502-505. (Pubitemid 39388390)
34. Gerstenfeld, L.C., Thiede, M., Seibert, K., Mielke, C., Phippard, D., Svagr, B., Cullinane, D., and Einhorn, T.A. (2003). Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J. Orthop. Res. 21, 670-675. (Pubitemid 36763489)
35. Irwin, M.G., Cheung, K.M., Nicholls, J.M., and Thompson, N. (1998). Intra-articular injection of ketorolac in the rat knee joint: effect on articular cartilage and synovium. Br. J. Anaesth. 80, 837-839. (Pubitemid 28282562)
36. Buvanendran, A., Kroin, J.S., Kari, M.R., and Tuman, K.J. (2008). A new knee surgery model in rats to evaluate functional measures of postoperative pain. Anesth. Analg. 107, 300-308.
37. Convery, P.N., Milligan, K.R., Quinn, P., Scott, K., and Clarke, R.C. (1998). Low-dose intra-articular ketorolac for pain relief following arthroscopy of the knee joint. Anesthesia 53, 1125-1129. (Pubitemid 28505350)
38. Ma, W. and Eisenach, J.C. (2003). Intraplantar injection of a cyclooxygenase inhibitor ketorolac reduces immunoreactivities of substance P, calcitonin gene-regulated peptide, and dynorphin in the dorsal horn of rats with nerve injury or inflammation. Neuroscience 121, 681-690. (Pubitemid 38367507)
39. Dong, L., Guarino, B.B., Jordan-Sciutto, K.L., and Winkelstein, B.A. (2011). Activating transcription factor 4, a mediator of the integrated stress response, is increased in the dorsal root ganglia following painful facet joint distraction. Neuroscience 193, 377-386.
40. Dong, L. and Winkelstein, B.A. (2010). Simulated whiplash modulates expression of the glutamatergic system in the spinal cord suggesting spinal plasticity is associated with painful dynamic cervical facet loading. J. Neurotrauma 27, 163-174.
41. Lee, K.E., Davis, M.B., and Winkelstein, B.A. (2008). Capsular ligament involvement in the development of mechanical hyperalgesia after facet joint loading: behavioral and inflammatory outcomes in a rodent model of pain. J. Neurotrauma 25, 1383-1393.
42. Zimmermann, M. (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110. (Pubitemid 13058546)
43. Quinn, K.P., Dong, L., Golder, F.J., and Winkelstein, B.A. (2010). Neuronal hyperexcitability in the dorsal horn after painful facet joint injury. Pain 151, 414-421.
44. Hubbard, R.D. and Winkelstein, B.A. (2005). Transient cervical nerve root compression in the rat induces bilateral forepaw allodynia and spinal glial activation: Mechanical factors in painful neck injuries. Spine 30, 1924-1932. (Pubitemid 41292215)
45. Lee, K.E., Thinnes, J.H., Gokhin, D.S., and Winkelstein, B.A. (2004). A novel rodent neck pain model of facet-mediated behavioral hypersensitivity: Implications for persistent pain and whiplash injury. J. Neurosci. Methods 137, 151-159. (Pubitemid 38942875)
46. Rothman, S.M., Kreider, R.A., and Winkelstein, B.A. (2005). Spinal neuropeptide responses in persistent and transient pain following cervical nerve root injury. Spine 30, 2491-2496. (Pubitemid 41669083)
47. Dong, L., Odeleye, A.O., Jordan-Sciutto, K.L., and Winkelstein, B.A. (2008). Painful facet joint injury induces neuronal stress activation in the DRG: Implications for cellular mechanisms of pain. Neurosci. Lett. 443, 90-94.
48. Rothman, S.M. and Winkelstein, B.A. (2010). Cytokine antagonism reduces pain and modulates spinal astrocytic reactivity after cervical nerve root compression. Ann. Biomed. Eng. 38, 2563-2576.
49. Ma, W. and Eisenach, J.C. (2002). Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur. J. Neurosci. 15, 1037-1047. (Pubitemid 35469165)
50. Ma, W., Du, W., and Eisenach, J.C. (2002). Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res. 937, 94-99. (Pubitemid 34521770)
51. Bustamante, D. and Paeile, C. (1993). Ketorolac tromethamine: an experimental study of its analgesic effects in the rat. Gen. Pharmacol. 24, 693-698. (Pubitemid 23179249)
52. Sandrini M. (1999). Central effects of non-opiod analgesics review of actions and their clinical implications. CNS Drugs 12, 337-345.
53. Choi, M.S., Kim, Y.E., Lee, W.J., Choi, J.W., Park, G.H., Kim, S.D., Jeon, S.J., Go, H.S., Shin, S.M., Kim, W.K., Shin, C.Y., and Ko, K.H. (2008). Activation of protease-activated receptor1 mediates induction of matrix metalloproteinase-9 by thrombin in rat primary astrocytes. Brain Res. Bull. 76, 368-375.